MD306C2 - Remediu pentru profilaxia afecţiunilor vasculare, determinate de acţiunea peroxizilor glicoproteinfixaţi - Google Patents

Remediu pentru profilaxia afecţiunilor vasculare, determinate de acţiunea peroxizilor glicoproteinfixaţi

Info

Publication number
MD306C2
MD306C2 MD94-0391A MD940391A MD306C2 MD 306 C2 MD306 C2 MD 306C2 MD 940391 A MD940391 A MD 940391A MD 306 C2 MD306 C2 MD 306C2
Authority
MD
Moldova
Prior art keywords
vessels
diseases
peroxides
prophylactic
angiopathical
Prior art date
Application number
MD94-0391A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD306B1 (ro
Inventor
Schneider Werner
Meyer Britta
F. Elstner Erich
Original Assignee
Steigerwald Arzneimittelwerk Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk Gmbh filed Critical Steigerwald Arzneimittelwerk Gmbh
Publication of MD306B1 publication Critical patent/MD306B1/xx
Publication of MD306C2 publication Critical patent/MD306C2/ro

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MD94-0391A 1990-05-25 1994-11-25 Remediu pentru profilaxia afecţiunilor vasculare, determinate de acţiunea peroxizilor glicoproteinfixaţi MD306C2 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4016963A DE4016963A1 (de) 1990-05-25 1990-05-25 Verwendung von magnesium-pyridoxal-5'-phosphat-glutaminat zur verhinderung von erkrankungen, die sich infolge von gefaessschaeden ergeben
SU914895539A RU2041713C1 (ru) 1990-05-25 1991-05-24 Средство для профилактики сосудистых заболеваний, обусловленных действием гликопротеинсвязанных пероксидов

Publications (2)

Publication Number Publication Date
MD306B1 MD306B1 (ro) 1995-10-31
MD306C2 true MD306C2 (ro) 1996-02-29

Family

ID=6407228

Family Applications (1)

Application Number Title Priority Date Filing Date
MD94-0391A MD306C2 (ro) 1990-05-25 1994-11-25 Remediu pentru profilaxia afecţiunilor vasculare, determinate de acţiunea peroxizilor glicoproteinfixaţi

Country Status (28)

Country Link
US (1) US5372999A (OSRAM)
EP (1) EP0458287B1 (OSRAM)
JP (1) JPH07119174B2 (OSRAM)
KR (1) KR970005180B1 (OSRAM)
CN (1) CN1050750C (OSRAM)
AT (1) ATE142884T1 (OSRAM)
AU (1) AU651108B2 (OSRAM)
CA (1) CA2043228C (OSRAM)
CZ (1) CZ280683B6 (OSRAM)
DE (2) DE4016963A1 (OSRAM)
DK (1) DK0458287T3 (OSRAM)
EG (1) EG19730A (OSRAM)
ES (1) ES2091262T3 (OSRAM)
GR (1) GR3021077T3 (OSRAM)
HR (1) HRP931445B1 (OSRAM)
HU (1) HU219223B (OSRAM)
IE (1) IE76728B1 (OSRAM)
IL (1) IL98156A (OSRAM)
IN (1) IN173057B (OSRAM)
LT (1) LT3335B (OSRAM)
LV (1) LV10046B (OSRAM)
MD (1) MD306C2 (OSRAM)
MX (1) MX171883B (OSRAM)
RU (1) RU2041713C1 (OSRAM)
SI (1) SI9110925A (OSRAM)
SK (1) SK278896B6 (OSRAM)
UA (1) UA26973A1 (OSRAM)
ZA (1) ZA913692B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19527820A1 (de) * 1995-07-28 1997-01-30 Leniger Follert Elfriede Prof Arzneimittel zur Behandlung von Ulcera, insbesondere bei arteriellen und venösen Durchblutungsstörungen der Extremitäten, bei chronisch venöser Insuffizienz und Lymphödem
DE19532625C2 (de) * 1995-09-04 2000-04-20 Steigerwald Arzneimittelwerk Verfahren zur Herstellung von Magnesium-pyridoxal-5'-phosphat-glutamat und dabei erhaltene Zwischenprodukte
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
DE60023125T2 (de) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg Pyridoxal-analoge zur behandlung von störungen ausgelöst durch einen vitamin b6 mangel
CA2376029A1 (en) * 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003507418A (ja) * 1999-08-24 2003-02-25 メディキュア インターナショナル インコーポレイテッド 心血管疾患とその関連疾患の治療
US7442689B2 (en) * 2000-02-29 2008-10-28 Medicure International Inc. Cardioprotective phosphonates and malonates
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
RU2163132C1 (ru) * 2000-06-01 2001-02-20 Научно-исследовательский центр традиционной фитотерапии Способ лечения сердечно-сосудистых заболеваний фитопрепаратом и лекарственный сбор для лечения сердечно-сосудистых заболеваний
EP1299358B1 (en) 2000-07-07 2007-06-13 Medicure International Inc. Pyridoxine and pyridoxal analogues as cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US20070060549A1 (en) * 2004-08-10 2007-03-15 Friesen Albert D Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders
US7459468B2 (en) 2004-10-28 2008-12-02 Medicure International, Inc. Aryl sulfonic pyridoxines as antiplatelet agents
WO2006050598A1 (en) 2004-10-28 2006-05-18 Medicure International Inc. Dual antiplatelet/anticoagulant pyridoxine analogs
KR20100015578A (ko) 2007-03-14 2010-02-12 시에라 몰레큘러 코포레이션 세포 및/또는 거대분자의 보존 및/또는 안정화를 위한 조성물, 시스템 및 방법
RU2484843C1 (ru) * 2012-04-03 2013-06-20 Алексей Кириллович Пехтерев Лекарственный сбор растений для лечения сердечно-сосудистых заболеваний

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE246172C (OSRAM)
DE2461742C2 (de) * 1974-12-28 1983-01-27 Steigerwald Arzneimittelwerk Gmbh, 6100 Darmstadt Pyridoxin-5'-phosphorsäureester-Derivate sowie deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3807895A1 (de) * 1988-03-10 1989-09-21 Knoll Ag Erzeugnisse, enthaltend einen calciumantagonisten und einen lipidsenker

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Brevet nr. 0203649, EP, Int. cl. A 61 K 31 /66, 1987. *

Also Published As

Publication number Publication date
HU219223B (en) 2001-03-28
HRP931445A2 (en) 1996-02-29
EP0458287A2 (en) 1991-11-27
MD306B1 (ro) 1995-10-31
RU2041713C1 (ru) 1995-08-20
CA2043228A1 (en) 1991-11-26
CS156391A3 (en) 1992-02-19
KR970005180B1 (ko) 1997-04-14
CN1050750C (zh) 2000-03-29
IE911783A1 (en) 1991-12-04
IL98156A (en) 1996-06-18
GR3021077T3 (en) 1996-12-31
LV10046B (en) 1995-02-20
HRP931445B1 (en) 2000-04-30
IN173057B (OSRAM) 1994-02-05
DE69122170T2 (de) 1997-02-20
JPH04235130A (ja) 1992-08-24
ATE142884T1 (de) 1996-10-15
HUT58204A (en) 1992-02-28
US5372999A (en) 1994-12-13
CA2043228C (en) 1998-07-14
EP0458287A3 (en) 1992-04-08
CZ280683B6 (cs) 1996-04-17
EG19730A (en) 1996-01-31
IE76728B1 (en) 1997-11-05
HU911756D0 (en) 1991-12-30
SI9110925A (sl) 1998-06-30
EP0458287B1 (en) 1996-09-18
KR910019616A (ko) 1991-12-19
DK0458287T3 (da) 1996-10-07
CN1057391A (zh) 1992-01-01
IL98156A0 (en) 1992-06-21
LV10046A (lv) 1994-05-10
SK278896B6 (sk) 1998-04-08
DE4016963C2 (OSRAM) 1992-04-30
MX171883B (es) 1993-11-22
AU7730191A (en) 1991-11-28
LTIP580A (en) 1994-12-27
LT3335B (en) 1995-07-25
UA26973A1 (uk) 2000-02-28
DE4016963A1 (de) 1991-11-28
AU651108B2 (en) 1994-07-14
ZA913692B (en) 1992-02-26
ES2091262T3 (es) 1996-11-01
DE69122170D1 (de) 1996-10-24
JPH07119174B2 (ja) 1995-12-20

Similar Documents

Publication Publication Date Title
MD306C2 (ro) Remediu pentru profilaxia afecţiunilor vasculare, determinate de acţiunea peroxizilor glicoproteinfixaţi
GB2282140A (en) Purified forms of DNAse
PT831882E (pt) Composicoes de segmentos de fibra de colagenio reconstituido e metodos de preparacao das mesmas
PT91351A (pt) Processo para a preparacao de derivados de alcoxi-4-(1h)-piridona e de composicoes farmaceuticas que os contem
HU9503627D0 (en) New 9-cis-retinoid derivatives
BR9913662A (pt) Método e aparelho para a monitoração de uma pessoa
SI0801564T1 (en) Use of nebivolol as an anti-atherogenic
ZA966798B (en) Methods of reducing or maintaining reduced levels of blood lipids using OB protein compositions.
EP0393493A3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
AU2742892A (en) An anticoagulant substance obtained from urine
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
BR9708388A (pt) Solução aquosa de hemoglobina polimerizada piridoxilada e processo de sua preparação.
MD545G2 (ro) Preparat medicamentos
Sztajzel et al. Heroin abuse and myocardial infarction
AU7718796A (en) 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
MD950010A (ro) Compoziţie pentru înlăturarea sau dezactivarea componentelor dăunătoare în sînge sau alte lichide extracelulare ale organismului şi procedeu de obţinere
Newell Pentaerythritol tetranitrate (sustained action) in acute myocardial infarction
DE69109293D1 (de) Verwendung von 20(r)-22-oxa-vitamin d analoge zur herstellung eines medikaments für die behandlung des altershaut.
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
MD20000092A (en) Method of prognosticating the cardiac insufficiency syndrome evolution
Reid Poisoning due to snake bite
ATE83931T1 (de) Methode fuer die behandlung von viraler gehirnentzuendung.
Platt Thrombocytopenic purpura apparently due to tablets containing salicylamide and mephenesin (“Arthripax”)

Legal Events

Date Code Title Description
FG4A Patent for invention issued
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20110524